Retractable Technologies (NYSE:RVP) Receives New Coverage from Analysts at StockNews.com

StockNews.com initiated coverage on shares of Retractable Technologies (NYSE:RVPFree Report) in a report issued on Wednesday morning. The brokerage issued a hold rating on the stock.

Retractable Technologies Trading Down 1.7 %

Shares of NYSE RVP opened at $1.14 on Wednesday. The company has a market cap of $34.13 million, a price-to-earnings ratio of -4.38 and a beta of 2.07. The stock’s 50 day simple moving average is $1.06 and its 200 day simple moving average is $1.14. Retractable Technologies has a 12-month low of $0.87 and a 12-month high of $1.34. The company has a current ratio of 11.02, a quick ratio of 8.18 and a debt-to-equity ratio of 0.01.

Retractable Technologies (NYSE:RVPGet Free Report) last announced its quarterly earnings data on Wednesday, May 15th. The company reported $0.01 earnings per share for the quarter. The business had revenue of $7.60 million during the quarter. Retractable Technologies had a negative return on equity of 7.55% and a negative net margin of 18.84%.

Insider Transactions at Retractable Technologies

In related news, CEO Thomas J. Shaw bought 48,635 shares of the company’s stock in a transaction that occurred on Thursday, May 16th. The shares were acquired at an average price of $1.03 per share, with a total value of $50,094.05. Following the completion of the transaction, the chief executive officer now owns 14,417,148 shares of the company’s stock, valued at approximately $14,849,662.44. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders have acquired a total of 141,125 shares of company stock worth $144,620 in the last 90 days. 55.00% of the stock is owned by insiders.

About Retractable Technologies

(Get Free Report)

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.

Read More

Receive News & Ratings for Retractable Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Retractable Technologies and related companies with MarketBeat.com's FREE daily email newsletter.